Stay updated on Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.3.3 was added and the HHS Vulnerability Disclosure link along with Revision: v3.3.2 were removed.
    Difference
    0.2%
    Check dated 2025-12-22T22:23:45.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    A new revision (v3.3.2) has been added to the record history, and the previous revision (v3.3.1) has been removed.
    Difference
    0.1%
    Check dated 2025-12-01T16:09:33.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Revision history now lists a new version entry v3.3.1 and removes v3.2.0, representing a minor administrative update to the record. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T13:12:02.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The government funding status banner was removed from the page; it was a general site-wide notice and does not affect study details or records. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2025-11-17T06:28:21.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    Record History shows updates to Study Status and Recruitment Status across versions, indicating changes in the trial's activity and enrollment status.
    Difference
    0.1%
    Check dated 2025-11-03T01:12:08.000Z thumbnail image
  9. Check
    92 days ago
    Change Detected
    Summary
    Release 3.2.0 includes a prominent government funding/operating status notice and updates the version from 3.1.0 to 3.2.0.
    Difference
    13%
    Check dated 2025-10-05T09:56:57.000Z thumbnail image

Stay in the know with updates to Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial page.